Management of scleroderma-related end-stage renal disease with automated peritoneal dialysis.
Kidney failure is the principal cause of death in scleroderma and accounts for at least 50% of deaths in this disease. Management of scleroderma-related end-stage renal disease requires some form of renal replacement therapy. Survival up to 18 months has been reported in one patient on continuous ambulatory peritoneal dialysis. Surviving for more than 1 year on automated peritoneal dialysis has not been reported. We report a patient with scleroderma-related end-stage renal disease treated with automated peritoneal dialysis with steady state control of uremia and hypertension at 18 months of follow-up.
Pavan
Malleshappa
M
Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India. dr_pavanm@yahoo.co.in
Aiyangar
Ashwinikumar
A
Chaudhari
Anup
A
Rajputh
Prashanth
P
Ranganath
Ravi
R
Babulal
Shah Arunkumar
SA
D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy*; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods*; D012595:Scleroderma, Systemic / Q000150:complications*